Cite
HARVARD Citation
Ascierto, P. et al. (n.d.). Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP). Journal for immunotherapy of cancer. p. . [Online].